Planning for the Best

Tripartite National Strategic Plan for Radiation Oncology 2012-2022

The copyright of the content published in this website is with The Royal Australian and New Zealand College of Radiologists unless otherwise stated.

« Previous page Next page »

References

  1. Cancer Council Australia. Facts and Figures. Sydney: Cancer Council Australia [updated 2011 October 24; cited 2012 May 29]. Available from: http://www.cancer.org.au/Newsmedia/factsfigures.htm
  2. Australian Institute of Health and Welfare 2012. Cancer incidence projections: Australia, 2011 to 2020. Cancer Series no. 66. Cat. No. CAN 62. Canberra: AIHW.
  3. Burridge N, Amer A, Marchant T, et al. Online Adaptive Radiotherapy of the Bladder: Small Bowel Irradiated-Volume Reduction. International Journal of Radiation Oncology Biology and Physics 2006; 66:892-897.
  4. Foroudi F, Kron T, Haworth A, et al. Adaptive Radiotherapy using Target CT for muscle invasive bladder cancer: a new component of trimodality therapy for organ preservation. British Journal of Urology International 2008; 101:28-29.
  5. Chang JH, Lim Joon D, Lee ST, Gong SJ, Anderson NJ, Scott AM, Davis ID, Clouston D, Bolton D, Hamilton CS, Khoo V. Intensity Modulated Radiation Therapy Dose Painting for Localized Prostate Cancer Using (11)C-choline Positron Emission Tomography Scans. International Journal of Radiation Oncology*Biology*Physics. 2012 May 30; Article in Press.
  6. Mak D, Corry J, Lau E, Rischin D, Hicks RJ. Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma. Quarterly Journal of Nuclear Medicine Molecular Imaging. 2011 Oct;Volume 55(No 5):487-99.
  7. Barber TW, Duong CP, Leong T, Bressel M, Drummond EG, Hicks RJ. 18F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer: A Prospective Study with Mature Survival Data. Journal of Nuclear Medicine. 2012 Jun;Volume 53(No 6): p864-71.
  8. Van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359: p1388–93.
  9. Fischer B, Lassen U, Mortensen J, et al. Preoperative staging of lung cancer with combined PET-CT. New England Journal of Medicine 2009; 361: p32–39.
  10. Ruers TJ, Wiering B, van der Sijp JR, et al. Improved selection of patients for hepatic surgery of colorectal liver metastases with 18F-FDG PET: a randomized study. Journal of Nuclear Medicine 2009; 50: p1036–41.
« Previous page Next page »